BridgeBio takes crown for biggest biotech IPO of 2019, as fellow unicorn Adaptive raises offering size and price
BridgeBio Pharma and Adaptive Biotechnologies have not just upsized IPO offerings — the pair of unicorns have also raised their offering prices above the range …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
